Business Model & Economics
Break-even in Month 7 with 214 customers
Gross Margin: 78% | Payback Period: 1.2 months
Revenue Model Overview
Primary: Consumer SaaS (65%)
Freemium subscription model targeting patients and caregivers directly. Recurring revenue provides predictability while the free tier drives user acquisition and trial matching data.
Secondary: B2B Recruitment (30%)
Fee-per-qualified-lead partnerships with pharma companies and CROs. Leverages our patient intent data to deliver pre-qualified, engaged trial candidates at lower cost than traditional recruitment.
Tertiary: Enterprise Licensing (5%)
White-label platform licensing for hospital systems and research institutions. Provides patient engagement tools while maintaining institutional branding and compliance requirements.
Pricing Strategy & Tier Structure
Market Benchmark Comparison
| Competitor | Entry Price | Your Position |
|---|---|---|
| Antidote (acquired) | B2B only | Consumer focus |
| ClinicalTrials.gov | Free | Value-added |
| Your Solution | $0-9.99 |
Pricing Psychology
- Anchor pricing: Free tier establishes value, $9.99 feels accessible for healthcare
- Annual discount: $99/year (17% savings) improves retention
- Good-Better-Best: Clear upgrade path from free to premium
- Psychological pricing: $9.99 vs $10 creates perception of value
Customer Acquisition Economics
CAC Breakdown by Channel
| Channel | Monthly Spend | Conversions | CAC |
|---|---|---|---|
| Health Forums/Communities | $1,500 | 25 | $60 |
| Google Ads (Health) | $2,000 | 20 | $100 |
| Social Media (FB/IG) | $1,500 | 15 | $100 |
| Referral Program | $300 | 12 | $25 |
| Total | $5,300 | 72 | $74 |
CAC Improvement Plan
Organic Multiplier: 30% of signups from organic search/word-of-mouth by Month 12, reducing effective CAC to $52.
Lifetime Value (LTV) Analysis
LTV Calculation
LTV:CAC Ratio: $974 / $74 = 13.2:1
Payback Period: $74 / ($7.49 × 0.78) = 1.3 months
Retention Cohort Analysis
Industry Context: Healthcare SaaS typically sees 4-8% monthly churn. Our 6% target is achievable given high user intent and life-impacting value proposition.
Cost Structure & Margins
Fixed Costs (Monthly)
| Founder Salaries (2) | $8,000 |
| Software/Tools | $800 |
| Legal/Compliance | $500 |
| Marketing/Brand | $1,200 |
| Total Fixed | $10,500 |
Variable Costs (Per User)
| AI API Costs | $1.80 |
| Cloud Hosting | $0.50 |
| Database | $0.20 |
| Payment Processing | $0.30 |
| Total Variable | $2.80 |
Blended Margin: 78% (includes free tier support costs)
Break-Even Analysis
Break-Even Calculation
Path to Profitability
Funding Requirement: $500K seed provides 18-month runway to achieve $22K/month profit with significant growth capital.
3-Year Financial Projections
Regulatory & Compliance Considerations
Business Structure
Delaware C-Corp recommended for VC funding path, IP protection, and institutional investor requirements. Enables clean equity structure for future rounds.
Data Privacy
HIPAA compliance essential for health data handling. GDPR/CCPA for international users. Annual compliance cost: $15K (legal + certification).
Insurance
Cyber liability ($2.5K/yr), professional liability ($1.8K/yr), and D&O insurance ($3K/yr) required for B2B contracts and investor requirements.
Business Model Risks & Mitigations
Healthcare-focused AI models may see significant pricing increases as demand grows. A 3x cost increase would reduce gross margins from 78% to 52%, threatening unit economics.
Mitigation: Implement multi-provider AI strategy with fallback options, negotiate volume discounts at scale, and develop proprietary fine-tuned models to reduce dependency on expensive general-purpose APIs.
Pharma and hospital sales cycles typically take 6-18 months, creating cash flow gaps between customer acquisition and revenue recognition that could strain runway.
Mitigation: Focus initial B2B efforts on pilot programs with pre-negotiated expansion terms, maintain strong consumer revenue stream during enterprise sales cycles, and secure bridge financing for large opportunities.
Changes to clinical trial regulations or data privacy laws could require significant platform modifications or restrict data usage, impacting both consumer and B2B offerings.
Mitigation: Build modular architecture allowing quick compliance updates, engage legal counsel specializing in healthcare tech, and maintain transparent communication with users about data practices and regulatory changes.
Conclusion: Strong Economic Foundation
Clinical Trial Navigator demonstrates exceptional unit economics with a 13.2:1 LTV:CAC ratio, 78% gross margins, and break-even within 7 months. The dual revenue model (consumer + B2B) provides diversification while leveraging the same core technology. With $500K in seed funding, the business can achieve profitability while building a defensible position in the $2B+ clinical trial recruitment market.
Recommendation: Proceed with seed round targeting healthcare-focused VCs, emphasizing the capital-efficient path to $3.3M ARR by Year 3 with strong margins and defensible moat through patient intent data.